INTERCEPT PHARMACEUTICALS, INC. Annual Interest Expense in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2016 to 2022.
  • Intercept Pharmaceuticals, Inc. Interest Expense for the quarter ending September 30, 2023 was $1.8M, a 65.6% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. Interest Expense for the twelve months ending September 30, 2023 was $11.7M, a 64.1% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Interest Expense for 2022 was $21.4M, a 60.7% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Interest Expense for 2021 was $54.4M, a 13.2% increase from 2020.
  • Intercept Pharmaceuticals, Inc. annual Interest Expense for 2020 was $48.1M, a 16.8% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $21.4M -$33M -60.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 $54.4M +$6.37M +13.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $48.1M +$6.91M +16.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $41.1M +$10.6M +34.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 $30.5M +$1.25M +4.28% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $29.3M +$15.1M +106% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $14.2M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.